<ѻý>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOLѻý> Patients report better urinary and bowel function outcomes Oct 24, 2022
<ѻý>Clinical Decision Tool Cuts Inappropriate BMA Therapy in Prostate Cancerѻý> Study at VA center shows better disease-related bone healthcare Sep 18, 2022
<ѻý>Long-Term ADT With Radiation Helps Prevent Post-Prostatectomy Metastasesѻý> However, no benefit seen with short-term hormone therapy versus radiotherapy alone Sep 13, 2022
<ѻý>Rezvilutamide Bests Bicalutamide in Metastatic Prostate Cancerѻý> Combined with ADT, the androgen-receptor inhibitor significantly improved OS, radiographic PFS Sep 07, 2022
<ѻý>A Light at the End of the Tunnel for Low-Risk Prostate Cancer?ѻý> The MUSIC model might improve quality of life and prevent overtreatment Sep 02, 2022
<ѻý>How Realistic Is Radical Prostatectomy Without Prior Biopsy?ѻý> German case series suggests it may be feasible Jul 12, 2022
<ѻý>MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancerѻý> QOL outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said Jun 17, 2022
<ѻý>Xtandi During AS Reduced Progression Risk in Early Prostate Cancerѻý> Risk of disease progression cut by 46% versus those on active surveillance alone Jun 16, 2022
<ѻý>P53 Antagonist Shows Early Activity in Advanced Liposarcomaѻý> ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
<ѻý>She Found Out She Had Prostate Cancerѻý> Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
<ѻý>Just How Effective Is PSA Screening?ѻý> Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
<ѻý>Mental Health Issues Common, Often Overlooked in Prostate Cancerѻý> More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
<ѻý>Urologists Are Helping Combat the Opioid Epidemic, Studies Suggestѻý> Three reports show success in reducing opioid prescribing May 16, 2022
<ѻý>End of the Line for a Failed Prostate Cancer Drugѻý> Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
<ѻý>Another Link Between Prostate Cancer Hormone Tx and Impaired Cognitionѻý> Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
<ѻý>Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dxѻý> Consistently low PSA levels failed to signal metastasis Apr 18, 2022
<ѻý>Genetic Score Shows Promise for Honing PSA Precisionѻý> Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
<ѻý>$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rightsѻý> Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
<ѻý>Cancer May Heighten Odds of Guillain-Barre Syndromeѻý> Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
<ѻý>Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancerѻý> Docetaxel-enzalutamide regimen may offer another option for men who progressed on AR inhibitor Feb 18, 2022
<ѻý>Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPCѻý> In one case, rPFS benefit was seen regardless of HRR mutational status Feb 18, 2022
<ѻý>Darolutamide Improves OS in Metastatic Prostate Cancerѻý> The AR inhibitor plus standard therapy led to a 32% reduced risk of death versus placebo Feb 17, 2022
<ѻý>Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancerѻý> In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo Feb 10, 2022
<ѻý>We've Never Really Understood the Prostateѻý> Wolinsky reviews Ericka Johnson's new book, A Cultural Biography of the Prostate Jan 19, 2022
<ѻý>In Early Prostate Cancer, Black Men Do Better With Radiotherapy Than White Menѻý> "Unexpected" finding holds even though Black men are more likely to have high-risk features Dec 29, 2021
<ѻý>NCCN Reverses on Guideline Change for Surveillance in Prostate Cancerѻý> Active surveillance again preferred choice for "most" men with low-risk disease Dec 01, 2021
<ѻý>Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancerѻý> No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
<ѻý>Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancerѻý> Prolonged adjuvant ADT also improved survival Oct 27, 2021
<ѻý>Potential New Standard for Post-Prostatectomy Radiotherapyѻý> Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
<ѻý>Cognitive Therapy Boosts Penile Injection Compliance Post-Prostatectomyѻý> Men became more comfortable with treatment to ward off ED, study suggests Oct 25, 2021
<ѻý>Benefits of Post-Op Penile Traction Therapy Hold Up Over Timeѻý> Improvements in length, function seen at 9 months after prostatectomy Oct 23, 2021
<ѻý>Androgen-Targeting Combos Show Promise in Prostate Cancerѻý> Trials extend survival in hormone-sensitive disease Sep 21, 2021
<ѻý>Best Way to Recover Urinary Continence After Prostatectomy?ѻý> Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
<ѻý>Which Prostate Biopsy Is Best: Transrectal or Transperineal?ѻý> Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
<ѻý>Plant-Based Diet Tied to Better Urological Health in Menѻý> "Eat more plants for your prostate and your erections Sep 12, 2021
<ѻý>Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancerѻý> Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
<ѻý>PSMA PET Plus MRI Better Detects Clinically Significant Prostate Cancersѻý> Increase in negative predictive value and improved sensitivity versus MRI alone Sep 01, 2021
<ѻý>ADT Options for Prostate Cancer Come Out Even for Heart Safetyѻý> But low enrollment brought PRONOUNCE trial to an early close Aug 31, 2021
<ѻý>Robot-Assisted Prostatectomy Tied to Fewer Complicationsѻý> Taiwan study also saw shorter hospital stays versus open or laparoscopic surgeries Aug 25, 2021
<ѻý>When Is ADT Right for Biochemically Recurrent Prostate Cancer?ѻý> Study findings suggest early initiation may not "meaningfully" improve survival outcomes Aug 09, 2021